Astellas Pharma
Manufacturing · Japan · 10K+ Employees
View Company Info for Free
Overview
Headquarters
2-5-1 Nihonbashi-honcho Chuo-ku, Tokyo, ...Phone Number
+81 332443000Website
www.astellas.comRevenue
$12.7 BillionStock Symbol
4503Industry
About Astellas Pharma
Astellas Pharma Org Chart
Director, Americas Record To Report Controlle...
Controller & Senior Manager
Affiliate Controller (Canada)
Financial Controller
Assistant Affiliate Controller
Financial Controller
Director, Accounting Operations & Controller ...
Accounting, Greater Operations Controller (Ch...
Is Astellas Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Astellas Pharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if Astellas Pharma had a recent Job posting/layoffs
Astellas Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Astellas Pharma launches new products
Earning: See what the market has to say on Astellas Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Astellas Pharma has new funding data
Check out if Astellas Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Astellas Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Astellas Pharma
Find more new buyers
Company Profile Activity
Activity Insights
Astellas Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Astellas Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Astellas Pharma.
Astellas Pharma financials insights
Gather financial insights about Astellas Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$30M
Series B
$42.5M
Series C
$65M
Stock Offering
$75M
Astellas Pharma Tech Stack
A closer look at the technologies used by Astellas Pharma
Most Recent Scoops
Astellas Pharma News & Media
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
Late-breaking oral presentation highlights early signals of potential visual improvement and patient-reported outcomes of investigational ASP7317 in patients with advanced geographic atrophy (GA) Podium presentation focuses on the impact of IZERVAY® (avacincaptad pegol intravitreal...Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
SANGAMO THERAPEUTICS ENTERS INTO ASSET SALE AGREEMENTS WITH LILLY AND ASTELLASAstellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Astellas Pharma Inc. (ALPMY) Jefferies Global Healthcare Conference 2026 June 3, 2026 8:10 AM EDTCompany ParticipantsNaoki Okamura - President, CEO &...Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs
Faced with a future of evaporating Xtandi sales, Astellas has set out ambitions to license fresh assets while also continuing to tighten its belt. | Faced with a future of evaporating Xtandi sales, Astellas has set out ambitions to license fresh assets while also continuing to tighten its belt.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Astellas Pharma
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.... Read More